HIVE faculty member Kyle Cromer, PhD, was recently awarded a grant by the World Anti-Doping Agency (WADA) to develop technology to detect clandestine in vivo genome editing.
Cromer, an assistant professor in UCSF’s Department of Surgery, received the $150,000 grant from WADA’s Scientific Research Grant Program to work with Shai Carmi at Hebrew University of Jerusalem and Daniel Herstain of the Israel National Anti-Doping Agency.
Their project, “Advancing non-invasive detection of doping via in vivo genome editing,” is closely aligned with the Cromer lab’s interest in researching the intersection of CRISPR-based genome editing and cell engineering with special focus on hematopoietic stem cells and red blood cells.